Policy & Regulation
13 November 2018 - - US-based biopharmaceutical company Gilead Sciences, Inc. (NASDAQ: GILD) has presented new data from the company's clinical development programme for advanced fibrosis due to ...
13 November 2018 - - US-based biopharmaceutical company Gilead Sciences, Inc. (NASDAQ: GILD) has presented results from studies investigating Epclusa (sofosbuvir 400mg/velpatasvir 100mg) in chron...
13 November 2018 - - US-based RNAi therapeutics company Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), the leading, announced TODAY that the company presented updated results from the ongoing Phas...
13 November 2018 - - Swiss specialty biopharmaceutical group Ferring Pharmaceuticals Inc. has launched Nocdurna (desmopressin acetate), the first and only sublingual tablet approved in the United...
13 November 2018 - - Analysts at UK-based technology research and advisory company Technavio  forecast the global cervical cancer diagnostic testing market to grow at a CAGR of over 6% durin...
13 November 2018 - - Japanese drugmaker Eisai Co., Ltd. and US-based Merck (NYSE: MRK) have received results from presentations of new data and analyses of Lenvima (lenvatinib), an orally available ki...
Related Headlines